Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Daxor Corporation DXR
$11.60
-$1 (-8.59%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
54293066.00000000
-
week52high
14.55
-
week52low
7.81
-
Revenue
6310294
-
P/E TTM
9
-
Beta
-0.54186800
-
EPS
0.87000000
-
Last Dividend
5.10500000
-
Next Earnings Date
02 мар 2023 г. в 14:00
Описание компании
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Maxim Group | Buy | 29 июл 2019 г. | |
| Ascendiant | Buy | 16 мая 2019 г. | |
| Ascendiant Capital | Buy | 16 мая 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Michel Robert J | A | 7250 | 1000 | 18 ноя 2022 г. |
| DesRosiers Caleb | A | 3157 | 3157 | 17 ноя 2022 г. |
| LOMBARD JAMES A | A | 2000 | 2000 | 23 июн 2022 г. |
| Cremisi Henry D. | A | 2000 | 2000 | 23 июн 2022 г. |
| Goudie Joy S. | A | 2000 | 2000 | 23 июн 2022 г. |
| Feuer Edward | A | 2000 | 2000 | 23 июн 2022 г. |
| DesRosiers Caleb | A | 4000 | 4000 | 23 июн 2022 г. |
| LOMBARD JAMES A | A | 2100 | 2100 | 24 июн 2021 г. |
| Feuer Edward | A | 2100 | 2100 | 24 июн 2021 г. |
| Goudie Joy S. | A | 2100 | 2100 | 24 июн 2021 г. |
Новостная лента
Daxor Corporation (DXR) Q4 2022 Earnings Call Transcript
Seeking Alpha
06 мар 2023 г. в 15:04
Daxor Corporation (NASDAQ:DXR ) Q4 2022 Results Conference Call March 2, 2023 9:00 AM ET Company Participants Scott Gordon - President, Core IR Michael Feldschuh - CEO Robert Michel - CFO Conference Call Participants Anthony Vendetti - Maxim Group Evan Greenberg - Legend Cap Operator Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Daxor Corp. Fiscal Year 2022 Financial Results and Corporate Update Conference call.
Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewsWire
06 сент 2022 г. в 17:05
Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will attend the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12 – 14, 2022 at the Lotte New York Palace.
Daxor Corporation (DXR) Q2 2022 Earnings Call Transcript
Seeking Alpha
26 авг 2022 г. в 19:06
Daxor Corporation (NASDAQ:DXR ) Q2 2022 Earnings Conference Call August 25, 2022 4:30 PM ET Company Participants Scott Gordon - President and Co-Founder of CORE IR Michael Feldschuh - CEO & President Robert Michel - CFO Conference Call Participants Anthony Vendetti - Maxim Group Edward Wu - Ascendiant Capital Michael Samuels - Berthel Fisher Operator Good afternoon, and welcome to the Daxor Corporation First Half 2022 Financial Results and Corporate Update Conference Call. At this time, all participants are in listen-only mode.
Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update
GlobeNewsWire
24 авг 2022 г. в 16:40
Conference Call to be held on the same day at 4:30 p.m. Eastern Time